{"name":"Sarah Abdelbar Mahmoud","slug":"sarah-abdelbar-mahmoud","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Premixed bioceramic MTA","genericName":"Premixed bioceramic MTA","slug":"premixed-bioceramic-mta","indication":"Root canal obturation and sealing","status":"phase_3"}]}],"pipeline":[{"name":"Premixed bioceramic MTA","genericName":"Premixed bioceramic MTA","slug":"premixed-bioceramic-mta","phase":"phase_3","mechanism":"Premixed bioceramic MTA is a biocompatible calcium silicate-based cement that sets through hydration to form a hard matrix, used primarily as a root canal sealer and repair material in endodontic procedures.","indications":["Root canal obturation and sealing","Periapical surgery and repair","Pulp capping and pulpotomy","Perforation repair in endodontic treatment"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}